Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07133984 · ClinicalTrials.gov registry record
STICH3C Cardiac Magnetic Resonance Observational Study
A clinical trial of Ischemic Left Ventricle Systolic Dysfunction and Multivessel Coronary Artery Disease, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- 200
- Enrollment target
- 9
- Study locations
NCT07133984: Recruiting study of Ischemic Left Ventricle Systolic Dysfunction and Multivessel Coronary Artery Disease, sponsored by Weill Medical College of Cornell University.
NCT07133984 is a study of Ischemic Left Ventricle Systolic Dysfunction and Multivessel Coronary Artery Disease that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 200 participants. The trial reports 9 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07133984, a study of Ischemic Left Ventricle Systolic Dysfunction and Multivessel Coronary Artery Disease, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 9
- Study locations
Study Summary
STICOS will test the hypothesis that residual jeopardized myocardium, late gadolinium enhancement, and non-ischemic substrate after revascularization is associated with postoperative adverse cardiovascular events such as heart failure , readmission, or death. This study will look at whether certain heart tissue abnormalities seen on MRI scans can help predict serious health problems after heart procedures like stents or bypass surgery.
Primary Outcome
The primary objective of this study is to relate Cardiac Magnetic Resonance Imaging (CMR) (infarction, perfusion, and nonischemic substrate) after iLVSD revascularization with long-term outcomes.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Cardiac Magnetic Resonance Imaging
Study Locations (9)
Other
- MU Vienna Austria - Vienna
- Universite Laval Quebec (CRIUCPQ) Canada - Québec
- Sunnybrook Health Sciences Centre - Toronto
- Ruijin Hospital Shanghai Jiao Tong University School of Medicine - Shanghai
- Dedinje Cardiovascular Institute - Belgrade
New York
- NewYork-Presbyterian Brooklyn Methodist Hospital - Brooklyn
- New York Presbyterian - Queens - Flushing
- Weill Cornell Medicine/NewYork Presbyterian Hospital - New York
Alberta
- Libin Cardiovascular Institute - Calgary
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2030-01 |
What NCT07133984 shows while recruiting
NCT07133984 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Ischemic Left Ventricle Systolic Dysfunction appearing as the primary indexed condition, and to 1 intervention - of which Cardiac Magnetic Resonance Imaging is the first listed.
NCT07133984 lists 9 locations in 3 states (Other, New York, Alberta).
Frequently Asked Questions
What is clinical trial NCT07133984 about?
NCT07133984 is a clinical study titled "STICH3C Cardiac Magnetic Resonance Observational Study". STICOS will test the hypothesis that residual jeopardized myocardium, late gadolinium enhancement, and non-ischemic substrate after revascularization is associated with postoperative adverse cardiovascular events such as heart failure , readmission, or death. This study will look at whether certain...
What is the current status of trial NCT07133984?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2024-03-01. Estimated completion is 2030-01.
What conditions does trial NCT07133984 study?
This clinical trial studies the following conditions: Ischemic Left Ventricle Systolic Dysfunction, Multivessel Coronary Artery Disease.
What interventions are being tested in trial NCT07133984?
The interventions under investigation include: Cardiac Magnetic Resonance Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT07133984?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07133984 being conducted?
This trial has 9 study locations across New York, Alberta. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI